Be The Match BioTherapies presents at the Future Cell Therapy Commercialization Summit 2017
MINNEAPOLIS – June 2017
Be The Match BioTherapies® participated in the Future Cell Therapy Commercialization Summit 2017 in Boston, Mass., June 26-27.
On June 27, Molly McCormick, MA, CHTC, presented “The importance of patient case management to reduce variability in cell therapy supply chain.” McCormick is the vice president of Case Management and Operations Services at Be The Match BioTherapies’ parent company, the National Marrow Donor Program® (NMDP)/Be The Match®.
Her presentation was part of a series of sessions discussing “The demands of a cell therapy supply chain.”
About Be The Match BioTherapies
We partner with organizations pursuing new life-saving treatments in cellular therapy. Built on the foundation established over the last 30 years by the NMDP/Be The Match, we have unparalleled experience in personalized case management with a single point of contact, cell sourcing and collection, cell supply chain, immunogenetics and bioinformatics, research, and regulatory compliance.
By leveraging our proven capabilities and established relationships, we can bring customizable solutions to organizations in every stage of cellular therapy development — from discovery through commercialization. Discover how Be The Match BioTherapies can assist your company at BeTheMatchBioTherapies.com.